nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PNLIP—mouth—periodontitis	0.0622	0.155	CbGeAlD
Orlistat—ABHD16A—trigeminal ganglion—periodontitis	0.049	0.122	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—TIMP1—periodontitis	0.0487	0.0812	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—TLR2—periodontitis	0.0464	0.0775	CbGpPWpGaD
Orlistat—ABHD16A—parotid gland—periodontitis	0.0462	0.115	CbGeAlD
Orlistat—ABHD12—trigeminal ganglion—periodontitis	0.0459	0.115	CbGeAlD
Orlistat—PLA2G7—connective tissue—periodontitis	0.0434	0.108	CbGeAlD
Orlistat—ABHD12—parotid gland—periodontitis	0.0433	0.108	CbGeAlD
Orlistat—FASN—trigeminal ganglion—periodontitis	0.0385	0.0962	CbGeAlD
Orlistat—PNLIP—connective tissue—periodontitis	0.0381	0.0951	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL18—periodontitis	0.0357	0.0596	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—CCL2—periodontitis	0.0246	0.0411	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IFNG—periodontitis	0.0209	0.0349	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.0208	0.0348	CbGpPWpGaD
Orlistat—FASN—SREBF and miR33 in cholesterol and lipid homeostasis—PPARA—periodontitis	0.019	0.0316	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL1B—periodontitis	0.0187	0.0311	CbGpPWpGaD
Orlistat—PLA2G4A—trigeminal ganglion—periodontitis	0.0185	0.0462	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—MMP9—periodontitis	0.0176	0.0294	CbGpPWpGaD
Orlistat—PLA2G4A—connective tissue—periodontitis	0.0154	0.0384	CbGeAlD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—SERPINF2—periodontitis	0.0135	0.0225	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—SERPINF2—periodontitis	0.0135	0.0225	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.0123	0.0205	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—VDR—periodontitis	0.00949	0.0158	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—IL1A—periodontitis	0.00929	0.0155	CbGpPWpGaD
Orlistat—FASN—Activation of gene expression by SREBF (SREBP)—PPARA—periodontitis	0.00911	0.0152	CbGpPWpGaD
Orlistat—FASN—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—periodontitis	0.00727	0.0121	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—NTRK1—periodontitis	0.00697	0.0116	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—SERPINF2—periodontitis	0.00695	0.0116	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—SERPINF2—periodontitis	0.00695	0.0116	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TIMP1—periodontitis	0.00624	0.0104	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TIMP1—periodontitis	0.00624	0.0104	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00496	0.00828	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00496	0.00828	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—GGT1—periodontitis	0.00457	0.00762	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL3—periodontitis	0.00416	0.00695	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL3—periodontitis	0.00416	0.00695	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.00385	0.00642	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL3—periodontitis	0.00378	0.00631	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL3—periodontitis	0.00378	0.00631	CbGpPWpGaD
Orlistat—PNLIP—Disease—SLC52A3—periodontitis	0.00349	0.00582	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—SERPINF2—periodontitis	0.00339	0.00566	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TIMP1—periodontitis	0.00322	0.00537	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TIMP1—periodontitis	0.00322	0.00537	CbGpPWpGaD
Orlistat—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	0.0032	0.00534	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—periodontitis	0.00318	0.00531	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—VIP—periodontitis	0.00301	0.00502	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—VIP—periodontitis	0.00301	0.00502	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—SLC52A3—periodontitis	0.00292	0.00487	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—AGER—periodontitis	0.00291	0.00486	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—periodontitis	0.00283	0.00472	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—periodontitis	0.00273	0.00456	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—VIP—periodontitis	0.00273	0.00456	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—VIP—periodontitis	0.00273	0.00456	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCR2—periodontitis	0.00268	0.00448	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCR2—periodontitis	0.00268	0.00448	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—MMP1—periodontitis	0.00267	0.00445	CbGpPWpGaD
Orlistat—FASN—Disease—SLC52A3—periodontitis	0.00247	0.00412	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCR2—periodontitis	0.00244	0.00407	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCR2—periodontitis	0.00244	0.00407	CbGpPWpGaD
Orlistat—PNLIP—Disease—LTF—periodontitis	0.00237	0.00396	CbGpPWpGaD
Orlistat—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.00232	0.00387	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NOS2—periodontitis	0.00232	0.00386	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL3—periodontitis	0.00223	0.00373	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL3—periodontitis	0.00223	0.00373	CbGpPWpGaD
Orlistat—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00215	0.00359	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00215	0.00359	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGS2—periodontitis	0.00213	0.00355	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCR2—periodontitis	0.00209	0.00348	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCR2—periodontitis	0.00209	0.00348	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—ADRB1—periodontitis	0.00208	0.00347	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—ADRB1—periodontitis	0.00208	0.00347	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP1—periodontitis	0.00208	0.00347	CbGpPWpGaD
Orlistat—FASN—Metabolism—SLC52A3—periodontitis	0.00207	0.00345	CbGpPWpGaD
Orlistat—PNLIP—Disease—ACP5—periodontitis	0.00206	0.00343	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet homeostasis—NOS2—periodontitis	0.00203	0.00338	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—MMP1—periodontitis	0.002	0.00334	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—MMP1—periodontitis	0.002	0.00334	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP2—periodontitis	0.00199	0.00332	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCR2—periodontitis	0.0019	0.00316	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCR2—periodontitis	0.0019	0.00316	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—ADRB1—periodontitis	0.00189	0.00315	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—ADRB1—periodontitis	0.00189	0.00315	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.00186	0.0031	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.00186	0.0031	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL3—periodontitis	0.00185	0.00309	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—NOS2—periodontitis	0.0018	0.00301	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—NOS2—periodontitis	0.0018	0.00301	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINF2—periodontitis	0.00175	0.00292	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ACP5—periodontitis	0.00172	0.00287	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CCL2—periodontitis	0.00169	0.00282	CbGpPWpGaD
Orlistat—FASN—Disease—LTF—periodontitis	0.00168	0.0028	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VIP—periodontitis	0.00162	0.0027	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VIP—periodontitis	0.00162	0.0027	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP2—periodontitis	0.00161	0.00268	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TIMP1—periodontitis	0.00157	0.00262	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00154	0.00257	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00152	0.00254	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—periodontitis	0.00149	0.00249	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00148	0.00246	CbGpPWpGaD
Orlistat—FASN—Disease—ACP5—periodontitis	0.00145	0.00243	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCR2—periodontitis	0.00144	0.0024	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR2—periodontitis	0.00144	0.0024	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MMP3—periodontitis	0.00144	0.0024	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MMP3—periodontitis	0.00144	0.0024	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00143	0.00239	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00143	0.00239	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VIP—periodontitis	0.00134	0.00223	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—periodontitis	0.00134	0.00223	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00124	0.00206	CbGpPWpGaD
Orlistat—FASN—Metabolism—ACP5—periodontitis	0.00122	0.00203	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCR2—periodontitis	0.00119	0.00199	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCR2—periodontitis	0.00112	0.00187	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCR2—periodontitis	0.00112	0.00187	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ADRB1—periodontitis	0.00111	0.00186	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ADRB1—periodontitis	0.00111	0.00186	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00109	0.00182	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00104	0.00174	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.001	0.00167	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TGFB1—periodontitis	0.000959	0.0016	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—periodontitis	0.000959	0.0016	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GGT1—periodontitis	0.000958	0.0016	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL3—periodontitis	0.000951	0.00159	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL2—periodontitis	0.000934	0.00156	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL2—periodontitis	0.000934	0.00156	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCR2—periodontitis	0.000928	0.00155	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADRB1—periodontitis	0.000924	0.00154	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NTRK1—periodontitis	0.000913	0.00152	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NTRK1—periodontitis	0.000913	0.00152	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC52A3—periodontitis	0.000887	0.00148	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP3—periodontitis	0.000849	0.00142	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP3—periodontitis	0.000849	0.00142	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—periodontitis	0.000813	0.00136	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—periodontitis	0.000813	0.00136	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TIMP1—periodontitis	0.00081	0.00135	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000807	0.00135	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NTRK1—periodontitis	0.000756	0.00126	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—periodontitis	0.000738	0.00123	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—periodontitis	0.000738	0.00123	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000728	0.00121	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS2—periodontitis	0.000724	0.00121	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000708	0.00118	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP3—periodontitis	0.000703	0.00117	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—VIP—periodontitis	0.000688	0.00115	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARA—periodontitis	0.000685	0.00114	CbGpPWpGaD
Orlistat—FASN—Metabolism—GGT1—periodontitis	0.000678	0.00113	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000653	0.00109	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR2—periodontitis	0.000613	0.00102	CbGpPWpGaD
Orlistat—PNLIP—Disease—FGF2—periodontitis	0.00059	0.000984	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL3—periodontitis	0.000562	0.000938	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL2—periodontitis	0.000552	0.000921	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL2—periodontitis	0.000552	0.000921	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—periodontitis	0.000532	0.000888	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000526	0.000878	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ACP5—periodontitis	0.000523	0.000872	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—periodontitis	0.000512	0.000854	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MMP1—periodontitis	0.000503	0.00084	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FGF2—periodontitis	0.000499	0.000832	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FGF2—periodontitis	0.000499	0.000832	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000491	0.00082	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARA—periodontitis	0.000485	0.000809	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCR2—periodontitis	0.000477	0.000796	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADRB1—periodontitis	0.000475	0.000792	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.000468	0.000781	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000467	0.00078	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL2—periodontitis	0.000457	0.000763	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—periodontitis	0.000454	0.000757	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—periodontitis	0.000446	0.000744	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—periodontitis	0.000436	0.000728	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—periodontitis	0.000436	0.000728	CbGpPWpGaD
Orlistat—FASN—Disease—FGF2—periodontitis	0.000417	0.000697	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—periodontitis	0.000415	0.000692	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—periodontitis	0.000415	0.000692	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FGF2—periodontitis	0.000413	0.000689	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VIP—periodontitis	0.000406	0.000678	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000398	0.000664	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—periodontitis	0.000395	0.000658	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—periodontitis	0.000395	0.000658	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—periodontitis	0.000385	0.000642	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—periodontitis	0.000377	0.000628	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR2—periodontitis	0.000362	0.000604	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—periodontitis	0.000361	0.000603	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MMP3—periodontitis	0.000361	0.000603	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—periodontitis	0.000327	0.000546	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—periodontitis	0.000325	0.000543	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—periodontitis	0.000325	0.000543	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—periodontitis	0.000315	0.000526	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000304	0.000507	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT1—periodontitis	0.000291	0.000485	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—periodontitis	0.00029	0.000484	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR2—periodontitis	0.000282	0.00047	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB1—periodontitis	0.00028	0.000468	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—periodontitis	0.000272	0.000454	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—periodontitis	0.000269	0.00045	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—periodontitis	0.000245	0.000409	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—periodontitis	0.000245	0.000409	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—periodontitis	0.000241	0.000403	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—periodontitis	0.000235	0.000392	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK1—periodontitis	0.00023	0.000383	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP3—periodontitis	0.000213	0.000356	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARA—periodontitis	0.000208	0.000347	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000208	0.000347	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—periodontitis	0.000205	0.000342	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—periodontitis	0.000203	0.000339	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—periodontitis	0.000186	0.00031	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—periodontitis	0.000139	0.000232	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—periodontitis	0.000135	0.000226	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGF2—periodontitis	0.000125	0.000209	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ACP5—periodontitis	0.000122	0.000204	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—periodontitis	0.00011	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—periodontitis	0.000104	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—periodontitis	9.93e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—periodontitis	8.18e-05	0.000137	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT1—periodontitis	6.81e-05	0.000114	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—periodontitis	6.16e-05	0.000103	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARA—periodontitis	4.87e-05	8.13e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—periodontitis	3.17e-05	5.29e-05	CbGpPWpGaD
